⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACRS News
Aclaris Therapeutics, Inc.
Acrisure Completes Acquisition of Vave MGA from Canopius
businesswire.com
ACRS
Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138
globenewswire.com
ACRS
Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
globenewswire.com
ACRS
Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
globenewswire.com
ACRS
Cowboys Golf Club Unveils Multi-Million-Dollar Transformation
businesswire.com
ACRS
Form 8-K
sec.gov
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
ACRS
Excess Share Insurance (ESI) Launches Campio™ Powered by Acrisure®
prnewswire.com
ACRS
Form 8-K
sec.gov
ACRS